Header cover image

South African Pharmaceuticals & Biotech Potential Opportunities

UPDATED May 09, 2022

Companies that are potentially undervalued based on future cash flows and market ratios.

1 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
APNAspen Pharmacare HoldingsR152.00-10.7%-6.4%R68.5bR261.20PE11.7xE19.5%1.7%
Page 1 of 1